Conscious Sedation in TAVR: Is It Advisable?

The fundamental advantage offered by transcatheter aortic valve replacement (TAVR) has always been the fact that it is less invasive than surgical valve replacement. So far, most improvements for these devices have derived in less invasiveness (e.g., by improving the profile of the eluting system). However, there are also cases of “deployment” reduction during the procedure, and the use of transthoracic (instead of transesophageal) echocardiography, percutaneous access closure instead of surgery, and conscious sedation instead of general anesthesia is increasingly frequent.

Sedación consciente en TAVI: ¿Es recomendable?

There have been several single-center experiences proving the safety of conscious sedation during the procedure, which reduces the time spent in the cath lab and in the critical care unit, the global duration of hospital stay, and, obviously, costs.


Read also: Introducing the number one enemy of PCI: diabetes”.


The NCDR STS/ACC TVT Registry was designed to characterize the anesthesia choice and outcomes for all U.S. patients undergoing transfemoral TAVR between 2014 and 2015.

 

Conscious sedation was used in 1737/10,997 (15.8%) cases with a significant trend of increasing usage over time. The conscious sedation group was less likely to suffer in-hospital death (1.6% vs. 2.5%; p = 0.03), and 30-day death (2.9% vs. 4.1%; p = 0.03). Conversion to general anesthesia was necessary in only 5.9% of patients who initially underwent conscious sedation.


Read also: Additional Benefit from Radial Artery Graft in Myocardial Revascularization Surgery”.


After adjustment for 51 covariates, conscious sedation presented lower technical success (97.9% vs. 98.6%, p < 0.001), but was still associated with lower rates of in-hospital and 30-day death (1.5% vs. 2.4%; p < 0.001 and 2.3% vs. 4.0%; p < 0.001, respectively).

 

Conclusion

Conscious sedation during TAVR was associated with briefer length of stay and lower short-term mortality compared to TAVR under general anesthesia.

 

Editorial

Conscious sedation offers a range of varieties impossible to individualize in this work. It may go from local anesthesia only to an endovenous combination of benzodiazepines, opioids, or propofol, offering higher patient comfort; still, invasive ventilation is unnecessary in all cases.

 

Original title: Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the NCDR® STS/ACC TVT Registry.

Reference: Hyman MC et al. Circulation. 2017 Sep 1. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...